In patients undergoing dialysis, ferritin and transferrin saturation (TSAT) have been reported to be associated with erythropoiesis-stimulating agent responsiveness [7]; iron supplementation has been shown to be an independent factor that results in favorable erythropoiesis-stimulating agent responsiveness in patients with CKD [8]. The gene discussed is TF; the disease is chronic kidney disease.